In 2025, Health Canada has recast its methodology for overseeing pharmaceuticals, biologics, and innovative therapies.

Post-Market Drug Safety: From ICSRs to Real-World Data Integration in Global Pharmacovigilance Systems The lifecycle of a medicinal product only starts after approval.

As regional agencies deepen collaboration through platforms like PAHO and MERCOSUR, 2025 stands as the year when regulatory harmonization.